Adora Ndu, Pharm.D., J.D.
Board Member
Acadia Pharmaceuticals Inc (ACAD)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Adora Ndu, Pharm.D., J.D.
Adora Ndu, Pharm.D., J.D. is recorded as Board Member at Acadia Pharmaceuticals Inc (ACAD). Acadia Pharmaceuticals Inc reported in an 8-K filed May 29, 2026 that Adora Ndu, Pharm.D., J.D. was appointed Class I director, effective May 29, 2026. Acadia Pharmaceuticals Inc reported in an 8-K filed October 13, 2022 that Adora Ndu, Pharm.D., J.D. was appointed director, effective October 12, 2022.
“The following three Class I directors were elected by the votes indicated:”
“On October 10, 2022, upon the recommendation of our Nominating and Corporate Governance Committee, our Board of Directors (the "Board") increased the size of the Board from eight to nine members, and effective October 12, 2022, appointed Adora Ndu, Pharm.D., J.D. as a director to fill the newly created vacancy.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-10-12–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Acadia Pharmaceuticals Inc
Other people whose current roles at this company are on record from its filings.
- Catherine Owen Adams CEO, Board Member
- Stephen R. Biggar Chairman, Board Member
- Mark C. Schneyer CFO
- Mark Schneyer CFO
- Brendan P. Teehan COO
- Austin D. Kim General Counsel
- James K. Kihara Chief Accounting Officer
- Adora Ndu Board Member
- Daniel B. Soland Board Member
- Edmund P. Harrigan Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.